Viberzi is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Eluxadoline.
Product ID | 61874-100_0ad2e4fc-955d-41f7-a2ae-45e92b6bcefd |
NDC | 61874-100 |
Product Type | Human Prescription Drug |
Proprietary Name | Viberzi |
Generic Name | Eluxadoline |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2015-10-01 |
Marketing Category | NDA / NDA |
Application Number | NDA206940 |
Labeler Name | Allergan, Inc. |
Substance Name | ELUXADOLINE |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Opioid mu-Receptor Agonists [MoA], mu-Opioid Receptor Agonist [EPC] |
DEA Schedule | CIV |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2015-10-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206940 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-10-01 |
Marketing Category | NDA |
Application Number | NDA206940 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-10-01 |
Ingredient | Strength |
---|---|
ELUXADOLINE | 100 mg/1 |
SPL SET ID: | 7821bd40-4c84-4984-951b-6436ae20421a |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
61874-075 | Viberzi | Eluxadoline |
61874-100 | Viberzi | Eluxadoline |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VIBERZI 86803941 4982924 Live/Registered |
ALLERGAN HOLDINGS UNLIMITED COMPANY 2015-10-29 |
VIBERZI 86481014 4928665 Live/Registered |
ALLERGAN HOLDINGS UNLIMITED COMPANY 2014-12-15 |